Batavia Biosciences is a science-based contract development and manufacturing organization (CDMO) headquartered in Leiden, Netherlands, that partners with biopharmaceutical companies from DNA cloning through GMP-grade clinical manufacturing. Their core expertise lies in early-stage product development, offering services such as mammalian cell line generation, upstream process development, purification, product characterization, and viral vector and vaccine manufacturing. Unlike conventional CDMOs, Batavia positions itself as a product-development partner and thought leader, leveraging close collaboration with strategic EU and US partners to accelerate innovation. The company is driven by a mission to alleviate human suffering from infectious diseases and cancer through high-quality, personalized biopharmaceutical solutions.